Cargando…

Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands

BACKGROUND: The first HPV‐vaccine eligible cohorts in the Netherlands will enter the cervical screening program in 2023. However, a substantial number of young women already have had a cervical sample taken before entry into the regular screening program. This study was initiated to explore early ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schurink‐van ’t Klooster, Tessa M., Siebers, Albert G., Hoes, Joske, van Kemenade, Folkert J., Berkhof, Johannes, Bogaards, Johannes A., de Melker, Hester E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242855/ https://www.ncbi.nlm.nih.gov/pubmed/36965085 http://dx.doi.org/10.1002/cam4.5842

Ejemplares similares

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects
por: Hoes, Joske, et al.
Publicado: (2020)

Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients
por: Woestenberg, Petra J, et al.
Publicado: (2020)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
por: Hoes, J., et al.
Publicado: (2021)

O.4.5-3 Trend in sedentary behaviour in the Netherlands
por: Schurink-van 't Klooster, Tessa, et al.
Publicado: (2023)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Gender-specific mortality in DTP-IPV- and MMR ± MenC-eligible age groups to determine possible sex-differential effects of vaccination: an observational study
por: Schurink-van’t Klooster, Tessa M, et al.
Publicado: (2015)

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
por: Hoes, Joske, et al.
Publicado: (2018)

A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization
por: Vink, Margaretha A., et al.
Publicado: (2016)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
por: de Munter, A. C., et al.
Publicado: (2021)

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy
por: Aitken, Clare A., et al.
Publicado: (2019)

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis
por: Bogaards, Johannes A, et al.
Publicado: (2015)

Sex-Specific Immunization for Sexually Transmitted Infections Such as Human Papillomavirus: Insights from Mathematical Models
por: Bogaards, Johannes A., et al.
Publicado: (2011)

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Pricing of HPV vaccines in European tender-based settings
por: Qendri, Venetia, et al.
Publicado: (2018)

Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
por: Qendri, Venetia, et al.
Publicado: (2018)

Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands
por: Klooster, T. M. Schurink-van’t, et al.
Publicado: (2014)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study
por: Aitken, Clare A., et al.
Publicado: (2023)

Reflex cytology for triage of high‐risk human papillomavirus positive self‐sampled material in cervical cancer screening: a prospective cohort study
por: Loopik, DL, et al.
Publicado: (2020)

Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics
por: Aitken, Clare A., et al.
Publicado: (2021)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013
por: van der Horst, Judith, et al.
Publicado: (2017)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

Mumps transmission in social networks: a cohort study
por: Hahné, Susan, et al.
Publicado: (2017)

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2010)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
por: Donken, Robine, et al.
Publicado: (2016)

Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
por: Man, Irene, et al.
Publicado: (2020)

The added value of digital imaging to reflex cytology for triage of high‐risk human papillomavirus positive self‐sampled material in cervical cancer screening: A prospective cohort study
por: Wiersma, Danique, et al.
Publicado: (2022)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Identification of over- and undertreatment in the Dutch national cervical cancer screening program: A data linkage study at the hospital level
por: Vink, Maarten D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61fitnfn65baq17epsohhalms4